KONINKLIJKE DSM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114 EUR | +0.13% |
|
-.--% | -.--% |
| 05-31 | Dsm-firmenich to Build Centralized Financing Structure Under Cross Guarantee Deal | MT |
| 05-28 | Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements | MT |
Presenter SpeechRobert Routs (Executives)Ladies and gentlemen, shareholders, I hereby open the...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
02/06/2024
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
105.6
EUR
Average target price
121.9
EUR
Spread / Average Target
+15.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.62% | 896B | |
| +1.88% | 243B | |
| +29.39% | 181B | |
| +58.75% | 95.16B | |
| -7.33% | 72.44B | |
| -8.40% | 55.41B | |
| +36.57% | 36.26B | |
| -42.23% | 29.56B | |
| +66.00% | 29.24B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock
- News Koninklijke DSM
- Transcript : Koninklijke DSM N.V. - Shareholder/Analyst Call
